Medpace Holdings Inc (NAS:MEDP)
$ 390.55 -0.03 (-0.01%) Market Cap: 12.10 Bil Enterprise Value: 11.83 Bil PE Ratio: 39.81 PB Ratio: 18.02 GF Score: 94/100

Medpace Holdings Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 02:30PM GMT
Release Date Price: $114.75 (-2.74%)
Erin Elizabeth Wilson;dit Suisse AG
CrÃ;Research Division - Director and Senior Equity Research Analyst

© -

Welcome. Thanks, everybody. This is Erin Wright. I cover Life Sciences Tools, Diagnostics at

Crédit Suisse, and welcome to our 2020 Crédit Suisse Health Care Conference. Obviously, this will be in virtual format this year, so a little bit different. But if you do have questions for the company, you can e-mail me at [email protected].

And with this particular presentation in fireside chat, it will be audio only. So there's nothing wrong with your video, but this one will be uniquely in audio format only.

And with that, I'd like to introduce Medpace. With them, we have President and CEO, August Troendle; Jesse Geiger, CFO and COO of the Laboratory Business; and then also -- I think we also have Kevin Brady on, the Executive Director of Finance, as well.

So with that, I think I'll get it started with the Q&A.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot